Savvy Updates 3/31/25: Dexcom’s FDA Warning Letter & Response, CGM MARD Wars, Looking for Glucose Patterns, Microdosing GLP-1 Drugs, GLP-1 Drugs & The Brain & Peripheral Artery Disease, Islet Therapy Eliminates Severe Hypos & Reduces HbA1c, Beta Bionics iLet Sales Surge, SiBionics ‘World’s Thinnest’ CGM, Vicentra BV’s Kaleido 2 Insulin Patch Pump, Phenolic Preservatives & Inflammations, States to Curb Use of AI for Prior Authorizations

Savvy Updates 3/31/25: Dexcom’s FDA Warning Letter & Response, CGM MARD Wars, Looking for Glucose Patterns, Microdosing GLP-1 Drugs, GLP-1 Drugs & The Brain & Peripheral Artery Disease, Islet Therapy Eliminates Severe Hypos & Reduces HbA1c, Beta Bionics iLet Sales Surge, SiBionics ‘World’s Thinnest’ CGM, Vicentra BV’s Kaleido 2 Insulin Patch Pump, Phenolic Preservatives & Inflammations, States to Curb Use of AI for Prior Authorizations

Mar 31, 2025 | Advocacy, Diabetes Business, Featured, Research News, Technology Updates

In this week’s issue of The Savvy Diabetic:  Dexcom’s FDA Warning Letter & Dexcom’s Response Claims No Wrongdoing CGM MARD Wars, with Values without Context Looking for Glucose Patterns – See Trends & Possible Adjustments...
Savvy Updates 10/14/24: GLP-1s, Medtronic Recall, Breakthrough T1D & TCOYD, Sotagliflozin & FDA Appeal, How PBMs Work, CVS Break Up?, Non-D Above TTIR, Tidepool Loop

Savvy Updates 10/14/24: GLP-1s, Medtronic Recall, Breakthrough T1D & TCOYD, Sotagliflozin & FDA Appeal, How PBMs Work, CVS Break Up?, Non-D Above TTIR, Tidepool Loop

Oct 14, 2024 | Advocacy, Diabetes Business, Featured, LOOPing, Research News, Technology Updates, Videos

In this week’s issue of The Savvy Diabetic:  GLP-1s & T1D: How they work, dosing & pharmacokinetics Medtronic Recall for Reduced Battery Life Breakthrough T1D & TCOYD: Research Highlights Sotagliflozin (for CKD) & FDA Advocacy NOW! How PBMs...
Savvy Updates, 9/16/24: Abbott Libre 3 Recall, FDA Clears Modular Medical PODD1 Pump, Air Flight Can Disrupt Pump Insulin Delivery, Roche to Launch Accu-Chek Smartguide CGM, Ozempic/Mounjaro & Metformin, Abvance Therapeutics Gets $3.9M for Novel Insulin & Glucagon Formulation, Dexcom CGM Worn in Space for 1st Time, Drug Interactions with GLP-1 Agonists & SGLT-2 Inhibitors, Semaglutide Impact on Body Composition, 4 largest PBMs Control 70% of Prescription Drug Market, Banana Leaves as New Source of Protein Powder

Savvy Updates, 9/16/24: Abbott Libre 3 Recall, FDA Clears Modular Medical PODD1 Pump, Air Flight Can Disrupt Pump Insulin Delivery, Roche to Launch Accu-Chek Smartguide CGM, Ozempic/Mounjaro & Metformin, Abvance Therapeutics Gets $3.9M for Novel Insulin & Glucagon Formulation, Dexcom CGM Worn in Space for 1st Time, Drug Interactions with GLP-1 Agonists & SGLT-2 Inhibitors, Semaglutide Impact on Body Composition, 4 largest PBMs Control 70% of Prescription Drug Market, Banana Leaves as New Source of Protein Powder

Sep 14, 2024 | Diabetes Business, Featured, Foods, Research News, Technology Updates

Continuous Glucose Monitoring (CGM) Sensor Recall: Abbott Diabetes Care Inc Issues Recall for Certain FreeStyle Libre 3 Sensors due to Risk for Inaccurate High Glucose Readings posted by FDA.gov/medical-devices, 5 September 2024. This recall involves removing...
Skip to content